Amyris Biotechnologies, Inc. Adds $20 Million

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has expanded its Series B round from $70 million to around $90 million, according to a regulatory filing.